Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study
| author |
|
| created | [InstanceEdit:9685409] Jassal, Bijay, 2020-04-23 |
| dbId | 9685427 |
| displayName | Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study |
| journal | J. Clin. Oncol. |
| pages | 2492-9 |
| pubMedIdentifier | 26101246 |
| schemaClass | LiteratureReference |
| title | Belinostat in Patients With Relapsed or Refractory Peripheral T-Cell Lymphoma: Results of the Pivotal Phase II BELIEF (CLN-19) Study |
| url | http://www.ncbi.nlm.nih.gov/pubmed/26101246 |
| volume | 33 |
| year | 2015 |
Referrals
© 2026 Reactome
